The Open Press - Press Release News Wire
  Thursday, April 26th 2018 - 2:57pm EDT
  
PRESS RELEASE NEWS WIRE         
     FRONT PAGE     |     ARCHIVES     |     ABOUT US     |     FAQS      
Welcome Guest User  ( LOG IN )     SUBMIT A RELEASE   ADD A FIRM   
Sorting Options

By Country

By Metro Area

By Industry

Member Options


Register

Login

Recover Password

Email Alert
Site Navigation

Home

Services & Fees

Press Release Guidelines

Submit a Press Release

Company Directory

Contact Us

RSS Feeds

Help

|Press Releases|Pro PRs|Book Reviews|Articles (OP-ED)|News|Exposé|PR Firms|


Eli Lilly Zyprexa LIES!

Submitted by: Watchtower Whistleblower

2009-02-14 18:25:17

(OPENPRESS) February 14, 2009 -- Zyprexa cost me over $250.00 a month supply (co-payment) and has up to ten times the risk (over non users) of causing diabetes and severe weight gain.

Zyprexa which is only FDA approved for schizophrenia (.5-1% of pop) and some bipolar (2% pop) and then an even smaller percentage of theses two groups.
[I was wrongfully given it 'off label' for PTSD]

So how does Zyprexa get to be the 7th largest drug sale in the world?
Eli Lilly is in deep trouble for using their drug reps to 'encourage' doctors to write zyprexa for non-FDA approved 'off label' uses.
The drug causes increased diabetes risk,and medicare picks up all the expensive fallout.

Zyprexa has generated a lot of bad press for Eli Lilly and they still have unresolved Zyprexa settlement claims.
Eli Lilly is reaping the whirlwind for unethical marketing of Zyprexa that has caused suffering and deaths.

Eli Lilly promotes sales of their #1 drug (Zyprexa $4.8 billion per year) that can *cause* diabetes and then turns around and makes billions selling more drugs to treat the diabetes.
Eli Lilly's # 1 cash cow Zyprexa has been over-prescribed and linked to a 10-times greater risk of causing type #2 diabetes and increased risk of heart attack.

Zyprexa claims being stonewalled
Where is the (now up to) $4.6 billion Eli Lilly Zyprexa settlement going as many victim claimants haven't been paid yet? It's the largest pharma-fraud-whistleblower case in US history.

There must be millions out there harmed by this drug.
Recent studies have found that atypical antipsychotics used to control agitation in aggressive Alzheimer patients (chemical straight-jacket) have unacceptable risk.

At 5 to ten times the cost of the old standby thorazine,recent comparative studies show the diabetes inducing zyprexa class of drugs are only borderline better in controlling symptoms.

Daniel Haszard

(Only 9 percent of adult Americans think the pharmaceutical industry can be trusted right around the same rating as big tobacco. )




Contact Info

Watchtower Whistleblower
Phone: 207-433-7627
Website: http://www.dannyhaszard.com
POB 1503 Bangor Maine 04402-1503


 


Copyright © 2018
The Open Press - Professional Press Release News Wire.
All rights reserved.


   Home|About Us|Archives|Faqs|Services & Fees|Guidelines|Submit Release|Register|Company Directory|Contact Us|RSS Feeds|Email Alert